H-ras consensus sequence and mutations in primary hepatocellular carcinomas of lemurs and lorises

Veterinary Pathology

Volumn 48, Issue 4, 2011, Pages 868-874

  Cullen, John M ^a   Williams, C ^b   Zadrozny, L ^a   Otstot, J T ^c   Solomon, G G ^c   Sills, R C ^c   Hong, H H L ^c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

hepatocellular carcinoma; liver; molecular biology; oncology; primate; zoo

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; CONSENSUS SEQUENCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LEMURIDAE; LIVER CELL CARCINOMA; LIVER TUMOR; LORISIDAE; MALE; MUTATION; ONCOGENE RAS; PATHOLOGY; PRIMATE DISEASE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CONSENSUS SEQUENCE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; LEMUR; LIVER NEOPLASMS; LORISIDAE; MALE; MUTATION; PRIMATE DISEASES;

ANIMALIA; LEMURIDAE; LORIDAE; PAN; PRIMATES; RODENTIA; STREPSIRHINI;

EID: 79959781855     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810388526     Document Type: Article

References (35)

1. Aravalli RN,Steer CJ,Cressman EN.Molecular mechanisms of hepatocellular carcinoma.Hepatology. 2008;48:2047-2063.
2. Baba M,Yamamoto R,Iishi H,Tatsuta M.Ha-ras mutations in N-nitrosomorpholine-induced lesions and inhibition of hepatocarcinogenesis by antisense sequences in rat liver.Int J Cancer. 1997;72:815-820.
3. Benirschke K,Miller C,Ippen R,Heldstab A.The pathology of prosimians, especially lemurs.Adv Vet Sci Comp Med. 1985;30:167-208.
4. Bitsch A,Roschlau H,Deubelbeiss C,Neumann HG.The structure and function of the H-ras proto-oncogene are not altered in rat liver tumors initiated by 2-acetylaminofluorene, 2-acetylaminophenanthrene and trans-4-acetylaminostilbene.Toxicol Lett. 1993;67:173-186.
5. Boivin-Angele S,Lefrancois L,Froment O,Spiethoff A,Bogdanffy MS,Wegener K,Wesch H,Barbin A,Bancel B,Trepo C,Bartsch H,Swenberg J,Marion MJ.Ras gene mutations in vinyl chloride-induced liver tumours are carcinogen-specific but vary with cell type and species.Int J Cancer. 2000;85:223-227.
6. Carlson J,Heckerman D,Shani G. False discovery rate for 2×2 contingency tables. Microsoft Research technical report, MSRTR- 2009-53, 2010
7. Challen C,Guo K,Collier JD,Cavanagh D,Bassendine MF.Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas.J Hepatol. 1992;14:342-346.
8. Chen B,Liu L,Castonguay A,Maronpot RR,Anderson MW,You M.Dose-dependent ras mutation spectra in n-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors.Carcinogenesis. 1993;14:1603-1608.
9. Devereux TR,Foley JF,Maronpot RR,Kari F,Anderson MW.Ras proto-oncogene activation in liver and lung tumors from B6C3/F1mice exposed chronically to methylene chloride.Carcinogenesis. 1993;14:795-801.
10. Devereux TR,White CM,Sills RC,Bucher JR,Maronpot RR,Anderson MW.Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet.Carcinogenesis. 1994;15:1083-1087.
11. Dragani TA,Manenti G,Colombo BM,Falvella FS,Gariboldi M,Pierotti MA,Della Porta G.Incidence of mutations at codon 61 of the ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis.Oncogene. 1991;6:333-338.
12. Froment O,Boivin S,Barbin A,Bancel B,Trepo C,Marion MJ.Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.Cancer Res. 1994;54:5340-5345.
13. Gonzalez J,Benirschke K,Saltman P,Roberts J,Robinson PT.Hemosiderosis in lemurs.Zoo Biol. 1984;3:255-265.
14. Gotoh J,Obata M,Yoshie M,Kasai S,Ogawa K.Cyclin d1 over-expression correlates with beta-catenin activation, but not with h-ras mutations, and phosphorylation of akt, gsk3 beta and erk1/2 in mouse hepatic carcinogenesis.Carcinogenesis. 2003;24:435-442.
15. Harada N,Oshima H,Katoh M,Tamai Y,Oshima M,Taketo MM.Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.Cancer Res. 2004;64:48-54.
16. Jackson MA,Lea I,Rashid A,Peddada SD,Dunnick JK.Genetic alterations in cancer knowledge system: analysis of gene mutations in mouse and human liver and lung tumors.Toxicol Sci. 2006;90:400-418.
17. Lau KS,Haigis KM.Non-redundancy within the ras oncogene family: insights into mutational disparities in cancer.Mol Cells. 2009;28:315-320.
18. Manam S,Shinder GA,Joslyn DJ,Kraynak AR,Hammermeister CL,Leander KR,Ledwith BJ,Prahalada S,van Zwieten MJ,Nichols WW.Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors.Carcinogenesis. 1995;16:1113-1119.
19. Maronpot RR,Fox T,Malarkey DE,Goldsworthy TL.Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.Toxicology. 1995;101:125-156.
20. Nowak R. Walkeŕs Mammals of the World, 6th ed., vol. 1. Johns Hopkins University Press, Baltimore, MD, 1999
21. Reindel JF,Walsh KM,Toy KA Bobrowski WF.Spontaneously occurring hepatocellular neoplasia in adolescent cynomolgus monkeys (Macaca fascicularis).Vet Pathol. 2000;37:656-662.
22. Reynolds SH,Anna CK,Brown KC,Wiest JS,Beattie EJ,Pero RW,Iglehart JD,Anderson MW.Activated protooncogenes in human lung tumors from smokers.Proc Natl Acad Sci U S A. 1991;88:1085-1089.
23. Reynolds SH,Stowers SJ,Patterson RM,Maronpot RR,Aaronson SA,Anderson MW.Activated oncogenes in B6C3/F1mouse liver tumors: implications for risk assessment.Science. 1987;237:1309-1316.
24. Rothuizen J,Bunch SE,Charles J,Cullen JM,Desmet VJ,Szatmari V,Twedt DC,van den Ingh TSGAM,Van Winkle T,Washabau RJ. Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases (WSAVA).Elsevier Saunders, Philadelphia, PA, 2006:.
25. Shields JM,Pruitt K,McFall A,Shaub A,Der CJ.Understanding ras: it ain't over'til it's over. Trends Cell Biol. 2000;10:147-154.
26. Sills RC,Boorman GA,Neal JE,Hong HL,Devereux TR.Mutations in ras genes in experimental tumours of rodents.IARC Sci Pub1. 1999;:55-86.
27. Spelman LH,Osborn KG,Anderson MP.Pathogenesis of hemosiderosis in lemurs: role of dietary iron, tannin and ascorbic acid.Zoo Biol. 1989;8:239-251.
28. Tang Z,Qin L,Wang X,Zhou G,Liao Y,Weng Y,Jiang X,Lin Z,Liu K,Ye S.Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.Chin Med J (Engl). 1998;111:313-318.
29. Teufel A,Staib F,Kanzler S,Weinmann A,Schulze-Bergkamen H,Galle PR.Genetics of hepatocellular carcinoma.World J Gastroenterol. 2007;13:2271-2282.
30. Thorgeirsson SS,Grisham JW.Molecular pathogenesis of human hepatocellular carcinoma.Nat Genet. 2002;31:339-346.
31. Weihrauch M,Benicke M,Lehnert G,Wittekind C,Wrbitzky R,Tannapfel A.Frequent k-ras-2 mutations and p16(INK4A) methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.Br J Cancer. 2001;84:982-989.
32. Williams CV,Junge RE,Stalis IH.Evaluation of iron status in lemurs by analysis of serum iron and ferritin concentrations, total iron-binding capacity, and transferrin saturation.J Am Vet Med Assoc. 2008;232:578-585.
33. Wiseman RW,Stowers SJ,Miller EC,Anderson MW,Miller JA.Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3/F1 mouse.Proc Natl Acad Sci U S A. 1986;83:5825-5829.
34. You M,Candrian U,Maronpot RR,Stoner GD,Anderson MW.Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain a mouse.Proc Natl Acad Sci U S A. 1989;86:3070-3074.
35. Zadrozny LM,Williams CV,Remick AK,Cullen JM.Spontaneous hepatocellular carcinoma in captive prosimians.Vet Pathol. 2010;47:306-311.